BESPOKE EXTRACTS, INC.

BSPK ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Revenue $1.1M $785.5K $3.4K $35.6K $62.1K $15.9K
Cost of Revenue $664.5K $442.3K $1.1K $13.6K $3.5K $71.4K $22.9K
Gross Profit $452.9K $343.2K $2.3K $22.0K $4.5K $-9.3K $-7.0K
Gross Margin 40.5% 43.7% 66.3% 61.8% -15.0% -44.0%
Operating Expenses
Research & Development
SG&A Expense $1.3M $1.6M $3.7M $640.9K $-3.5M $6.8M
Operating Income $-994.6K $-1.5M $-4.0M $-965.6K $-4.0M $3.0M $-7.2M
Operating Margin -89.0% -187.4% -118,011.6% -2,714.9% 4,853.6% -45,169.7%
Interest Expense $535.7K $357.5K $419.0K
Pretax Income $-1.0M $-1.5M $-4.1M $-965.6K $-4.6M $2.6M $-7.6M
Income Tax Expense
Net Income $-1.0M $-1.5M $-4.1M $-965.6K $-4.6M $2.6M $-7.6M
Net Margin -92.8% -188.8% -120,816.8% -2,714.9% 4,155.6% -47,801.7%
EPS (Basic) $-0.10 $-0.15 $-0.44 $-0.19 $-0.04 $0.04 $-0.21
EPS (Diluted) $-0.10 $-0.15 $-0.44 $-0.19 $-0.04 $0.04 $-0.21
Shares Outstanding (Basic) 11.2M 10.5M 10.2M 9.4M 5.2M 229.4M 60.6M 35.4M
Shares Outstanding (Diluted) 11.2M 10.5M 10.2M 9.4M 5.2M 229.4M 60.6M 35.4M
Dividends Per Share
← Newer Page 1 of 2 Older →